子宫内膜上皮内瘤变或复杂非典型增生行子宫切除术时子宫内膜癌的术前预测因素
本回顾性队列研究纳入2004年1月至2015年12月因病理确诊子宫内膜上皮内瘤变行子宫切除术的169例患者,48.5%最终诊断为子宫内膜癌。子宫内膜厚度≥2 cm与合并子宫内膜癌的比值比为4.0(95%CI 1.5-10.0),年龄和子宫内膜厚度是最强预测因素。
要点
- 子宫内膜上皮内瘤变患者行子宫切除术时48.5%合并子宫内膜癌。
- 子宫内膜厚度≥2 cm者合并子宫内膜癌的比值比为4.0(95%CI 1.5-10.0)。
- 子宫内膜厚度≥2 cm的子宫内膜癌患者中44%符合Mayo标准需淋巴结清扫。
核心结论
- 子宫内膜厚度和年龄是因子宫内膜上皮内瘤变行子宫切除术时合并子宫内膜癌的最强预测因素。
- 子宫内膜厚度≥2 cm的子宫内膜上皮内瘤变患者合并癌率增加且可能需要淋巴结评估,作者认为转诊妇科肿瘤医生可能尤其必要。
研究设计与样本
- 回顾性队列研究,纳入2004年1月至2015年12月因病理确诊子宫内膜上皮内瘤变行子宫切除术的169例患者。
- 收集患者人口学、影像、病理和结局资料,采用Mayo标准判断需淋巴结清扫者。
- 连续变量用两样本t检验、分类变量用逻辑回归估计未校正关联,采用5折交叉验证的逻辑回归建立多变量模型。
主要发现
- 169例中87例(51.5%)最终诊断为子宫内膜上皮内瘤变/其他良性疾病,82例(48.5%)最终诊断为子宫内膜癌。
- 合并子宫内膜癌者平均子宫内膜厚度15.7 mm(标准差9.5) vs 无子宫内膜癌者12.5 mm(标准差6.4),P=.01。
- 控制年龄后,子宫内膜厚度≥2 cm与合并子宫内膜癌的比值比为4.0(95%CI 1.5-10.0)。
- 子宫内膜癌病例中87%为T1a期(Nx或N0)。
- 合并子宫内膜癌且子宫内膜厚度≥2 cm者中约44%符合Mayo标准需淋巴结清扫,而厚度<2 cm者为22%。
关键数值与推荐
- 采用Mayo标准判断需淋巴结清扫。
- 子宫内膜厚度≥2 cm合并子宫内膜癌的比值比为4.0(95%CI 1.5-10.0),控制年龄。
临床怎么用
- 作者认为,子宫内膜厚度≥2 cm的子宫内膜上皮内瘤变患者因合并癌率增加且可能需要淋巴结评估,转诊妇科肿瘤医生可能尤其必要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometrial intraepithelial neoplasia, also known as complex atypical hyperplasia, is a precancerous lesion of the endometrium associated with a 40% risk of concurrent endometrial cancer at the time of hysterectomy. Although a majority of endometrial cancers diagnosed at the time of hysterectomy for endometrial intraepithelial neoplasia are low risk and low stage, approximately 10% of patients ultimately diagnosed with endometrial cancers will have high-risk disease that would warrant lymph node assessment to guide adjuvant therapy decisions. Given these risks, some physicians choose to refer patients to a gynecologic oncologist for definitive management. Currently, few data exist regarding preoperative factors that can predict the presence of concurrent endometrial cancer in patients with endometrial intraepithelial neoplasia. Identification of these factors may assist in the preoperative triaging of patients to general gynecology or gynecologic oncology. OBJECTIVE: To determine whether preoperative factors can predict the presence of concurrent endometrial cancer at the time of hysterectomy in patients with endometrial intraepithelial neoplasia; and to describe the ability of preoperative characteristics to predict which patients may be at a higher risk for lymph node involvement requiring lymph node assessment at the time of hysterectomy. MATERIALS AND METHODS: We conducted a retrospective cohort study of women undergoing hysterectomy for pathologically confirmed endometrial intraepithelial neoplasia from January 2004 to December 2015. Patient demographics, imaging, pathology, and outcomes were recorded. The "Mayo criteria" were used to determine patients requiring lymphadenectomy. Unadjusted associations between covariates and progression to endometrial cancer were estimated by 2-sample t-tests for continuous covariates and by logistic regression for categorical covariates. A multivariable model for endometrial cancer at the time of hysterectomy was developed using logistic regression with 5-fold cross-validation. RESULTS: Of the 1055 charts reviewed, 169 patients were eligible and included. Of these patients, 87 (51.5%) had a final diagnosis of endometrial intraepithelial neoplasia/other benign disease, whereas 82 (48.5%) were ultimately diagnosed with endometrial cancer. No medical comorbidities were found to be strongly associated with concurrent endometrial cancer. Patients with endometrial cancer had a thicker average endometrial stripe compared to the patients with no endometrial cancer at the time of hysterectomy (15.7 mm; standard deviation, 9.5) versus 12.5 mm; standard deviation, 6.4; P = .01). An endometrial stripe of ≥2 cm was associated with 4.0 times the odds of concurrent endometrial cancer (95% confidence interval, 1.5-10.0), controlling for age. In all, 87% of endometrial cancer cases were stage T1a (Nx or N0). Approximately 44% of patients diagnosed with endometrial cancer and an endometrial stripe of ≥2 cm met the "Mayo criteria" for indicated lymphadenectomy compared to 22% of endometrial cancer patients with an endometrial stripe of <2 cm. CONCLUSION: Endometrial stripe thickness and age were the strongest predictors of concurrent endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia. Referral to a gynecologic oncologist may be especially warranted in endometrial intraepithelial neoplasia patients with an endometrial stripe of ≥2 cm given the increased rate of concurrent cancer and potential need for lymph node assessment.
引用
- Vetter MH, Smith B, Benedict J, et al. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstet Gynecol. 2019. PMID: 31401259. doi:10.1016/j.ajog.2019.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。